How does this sit with the 13d group I wonder? Will they say we are years away from an approval and this is nothing to be excited about? Beat the news down?

We know if they were in control of CYDY we would of stopped all trials and focused on just HIV until completion. They have mentioned that many times that we need to just focus on one thing at a time.

Is being purposely slow really the plan we want as a company going foreword? I think not… having all these many indication in trials right now and the future of 10 new indications a year in or started trials. Provides for future successes we all hope for is what I desire. Being anal and not seeing the big picture of the potential and the time necessary to prove our indications out is just not good business for the 13d group. Our current management has this under control and I would love nothing more than a BTD on Cancer before years end. Wouldn’t that be sweet… Go get’em Nader and seek our direction from the FDA and remind them they already granted us fast track status so let’s see what fast track actually does for us! Let us have that BTD for our safe molecule!